PGK1 and breast carcinoma: PGK1 expression was higher in TP53-mutant (total mutation rate: 34%), PAPPA2-mutant (total mutation rate: 2%), RB1-mutant (total mutation rate: 2%), DYNC1H1-mutant (total mutation rate: 2%), and CMYA5-mutant (total mutation rate: 2.7%) breast cancer patients (Figures 6A–C,E,F).